BioMap is an artificial intelligence (AI) therapeutics company that focuses on target identification and novel antibody modalities in the areas of immuno-oncology, autoimmune disease, etc. Its AI platform is built on real-world high-granularity patient data and proprietary automated high-throughput wet-lab data that it designs and generates internally. The goal is to use its AI capabilities to better decipher the complex immune system and design and optimize a new generation of biologics with novel therapeutic targets.